Skip to contentO
Odyssey Health, Inc.
O
ODYYOdyssey Health, Inc. Q4 2021 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income-$2.90M-$2.90MderivedN/M vs Q4 2020 EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$2,607,331N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Odyssey Health, Inc. · CIK 1626644 · Engraved from SEC EDGAR
Operating Cash Flowderived-$714,551N/M ended Jul 31, 2021 · filed Oct 29, 2021 · 90 d after period end